Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

KURAKURA
Showing 8 of 30 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in KURA ONCOLOGY INC

CITADEL ADVISORS LLC holds 368,825 shares of KURA (KURA ONCOLOGY INC), worth $3M as of 2026-Q1. The position was decreased (-5.6% shares). KURA represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$3M

Current Shares

368,825

Total Value Change

-$17.9M

Total Shares Change

-644,318

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
368,825
-5.6%
$3M0.0%$8.50
0
2025-Q4
Decreased
390,672
-51.7%
$4.1M0.0%$10.22
0
2025-Q3
Increased
808,818
+122.1%
$7.2M0.0%$8.97
44
2025-Q2
Decreased
364,155
-7.6%
$2.1M0.0%$5.67
0
2025-Q1
Decreased
394,241
-60.0%
$2.6M0.0%$7.05
0
2024-Q4
Decreased
986,951
-17.0%
$8.6M0.0%$8.51
0
2024-Q3
Increased
1.2M
+17.4%
$23.2M0.0%$19.52
33
2024-Q2
Increased
1M
+5392.2%
$20.9M0.0%$20.59
46

Other major holders of KURA: BlackRock Finance, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used